Hour-specific Transcutaneous Bilirubin in Healthy Term and Near-term Newborns of China

January 14, 2019 updated by: yangjie, Guangdong Women and Children Hospital
Make a neonatal jaundiced nomogram on Chinese jaundice data by joinning the major neonate centers all around China.

Study Overview

Status

Unknown

Conditions

Detailed Description

Jaundice in common amount Chinese newborn population. The neonatal jaundice guildline was made base on the AAP. guideline. Chinese newborn have their jaundice follow up and treatment plans make base on American neonatel jaundice data. Our group are now planning to have our own neonatel jaundice data by joinning the major neonate centers all around China. A neonatal jaundiced nomogram would be made base on Chinese neonatel jaundice data.

Study Type

Observational

Enrollment (Anticipated)

3000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Guangdong
      • Guangzhou, Guangdong, China, 511442
        • Jie Yang

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day to 1 week (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Term and near term newborns, whos gestational age was more than 35 weeks(≥35)

Description

Inclusion Criteria:

gestational age more than 35 weeks(≥35) -

Exclusion Criteria:

all kinds of congenital diseases, infants with pathologic jaundice

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hour-specific Transcutaneous Bilirubin Level
Time Frame: 1 year
make neonatal jaundiced nomogram base on the hour-specific transcutaneous bilirubin data
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Guangdong Women and Children Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

February 1, 2019

Primary Completion (ANTICIPATED)

March 31, 2019

Study Completion (ANTICIPATED)

December 31, 2019

Study Registration Dates

First Submitted

December 25, 2018

First Submitted That Met QC Criteria

January 14, 2019

First Posted (ACTUAL)

January 15, 2019

Study Record Updates

Last Update Posted (ACTUAL)

January 15, 2019

Last Update Submitted That Met QC Criteria

January 14, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Guangdong WCH

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Jaundice, Neonatal

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe